Drug Database
Back to search

Belgium· BE-AMP-SAM522044-00

Febuxostat EG 120 mg

A febuxostat product containing febuxostat hemihydrate, registered in Belgium by EG. The same ATC class is registered in 19 of our 19 countries.

ATC M04AA03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedFebuxostat EG 120 mgATCM04AA03REGISTER NO.BE-AMP-SAM522044-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about febuxostat hemihydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Febuxostat is registered in 19 of 19 countries.

Countries holding a registration under ATC M04AA03 (febuxostat), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 11 of them publish a price we can compare per daily dose
Search febuxostat products by name

Febuxostat · ATC M04AA03

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of febuxostat costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.34 in France to $1.89 in Switzerland — a ×5.6 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Febuxostat · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.89
  • IT Italy$0.69
  • ES Spain$0.54
  • FR France$0.34
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Febuxostat Hemihydrate
Manufacturer
EG
Country
Belgium (BE)
ATC code
M04AA03
ATC class
Febuxostat
Defined daily dose
80 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

1 priced
  • be_apb
    4247748
    EUR 30.61
  • be_apb
    7724362
  • be_apb
    3789617

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for febuxostat.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check febuxostat against other medicinesHow interaction checks work

Febuxostat · interactions on record

25 records

  • 6 severe
  • 19 moderate

Most severe, free to view

  • MercaptopurineL01BB02severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Febuxostat in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All febuxostat products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Bulgaria · Форур
  • Germany · Febuxostat Zentiva
  • Spain · Febuxostat Mabo
  • France · Febuxostat Zentiva Lab
  • Hungary · Forure
  • Italy · Uriquid
  • Romania · Forure

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdd27a4a-3d32-4d3c-8ba1-e417835a4074
GET /v1/drugs/cdd27a4a-3d32-4d3c-8ba1-e417835a4074?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Febuxostat EG 120 mg",
  "name_fr": "Febuxostat EG 120 mg",
  "name_nl": "Febuxostat EG 120 mg",
  "amp_code": "SAM522044-00",
  "strengths": [
    "123.4000",
    "123.4000",
    "120.0000",
    "120.0000",
    "42.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Febuxostat Hemihydrate",
    "Febuxostat",
    "Sodium Starch Glycolate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Febuxostat",
  "authorisation_numbers": [
    "BE522044"
  ]
}
API referenceMCP serverPlans

See everything about febuxostat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console